MENU

New generation of prophylactic footwear for diabetics

Development of and clinical tests on a new generation of prophylactic shoes for diabetics.

The aim of the project is to develop a new generation of footwear for diabetics who have been diagnosed with neuropathy of the feet. In respect of the importance of the problem, it is necessary to carry out clinical tests on the new characteristics of the footwear. The existence of such footwear will significantly reduce the possibility of damage to the feet of diabetics and will significantly contribute to protecting against further undesirable developments in their feet. At the same time, it is believed that the footwear could help in discussions on educating diabetic patients, facilitating the work of customs when declaring lower import duties and clarifying rules of partial or complete reimbursement of health insurance. Diabetes mellitus cannot be treated, only offset, and this compensation can effectively delay irreversible changes. It is estimated that for ten percent of diabetics, an important part of the lifestyle is wearing the correct footwear. Diabetes - diabetes mellitus - is one of the most widespread civilised diseases, which affects about 5 to 6 % of the population in developed countries. Furthermore, the percentage of diabetics is continuously rising. In 2007, it is expected that the number of diabetics in European countries will exceed 10 %. One of the most serious and most frequent complications includes changes in the feet of diabetics, called 'the diabetic foot'. As a rule, two groups of diagnoses are differentiated. The first is called the 'neuropathic diabetic foot', when a decrease in foot sensitivity occurs, the sweat glands gradually wither and there is a decrease in tendon strength supporting the longitudinal foot arch. Manifestations of neuropathic foot can be quite varied and mutually distinct. The second complication is called the 'angiopathic diabetic foot', and this is caused by a decrease in the functionality of the circulatory and nervous systems. Both of the above-mentioned complications manifest themselves most intensively in the feet of diabetics and are dangerous because in all cases, ulceration develops and diabetic gangrene can subsequently occur. As a rule in this case, surgical intervention is required, including amputation of toes (or amputation of parts of the foot). After foot amputation, nearly half the diabetic patients do not survive more than 3 years and only 20 % of patients survive 5 years. The majority of studies have shown that 60 - 80 % of all gangrene can be linked to wearing unsuitable footwear. Furthermore, several clinical studies have been published recently, in which it has been shown that wearing suitable footwear contributes to a significant decrease in the occurrence of undesirable complications. Keywords: footwear, diabetes, neuropathy.
Acronym: 
DIASHOE
Project ID: 
2 923
Start date: 
01-01-2003
Project Duration: 
56months
Project costs: 
630 000.00€
Technological Area: 
Dry filling related to Footwear / Leather Technology
Market Area: 
Handicap aids

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.